Role of connective tissue growth factor in mediating hypertrophy of human proximal tubular cells induced by angiotensin II

American Journal of Nephrology

Volumn 23, Issue 6, 2003, Pages 429-437

  Liu, Bi Cheng ^a,e   Sun, Jing ^a   Chen, Qi ^b   Ma, Kun Ling ^a   Ruan, Xiong Zhong ^c   Phillips, Aled O ^d  

^a AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e SOUTHEAST UNIVERSITY   (China)

Author keywords

Angiotensin II; Connective tissue growth factor; Human proximal tubular cell; Hypertrophy, cellular

Indexed keywords

ANGIOTENSIN; ANTIBODY; CONNECTIVE TISSUE GROWTH FACTOR; CONNECTIVE TISSUE GROWTH FACTOR ANTIBODY; LEUCINE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL COUNT; CELL CYCLE; CELL GROWTH; CELL LINE; CELL SIZE; CELL SORTER; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; FLOW CYTOMETRY; FLUORESCENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY HYPERTROPHY; KIDNEY PROXIMAL TUBULE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 0344394902     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074534     Document Type: Article

References (25)

1. Fine LG: The biology of renal hypertrophy. Kidney Int 1986;29:619-634.
2. Wolf G: Vasoactive factors and tubulointerstitial injury. Kidney Blood Press Res 1999;22:62-70.
3. Hannken T, Schroeder R, Stahl RAK, Wolf G: Atrial natriuretic peptide attenuates Ang II-induced hypertrophy of renal tubular cells. Am J Physiol 2001;281:F81-F90.
4. Kennefick TM, Anderson S: Role of angiotensin II in diabetic nephropathy. Semin Nephrol 1997;17:441-447.
5. Mezzano SA, Ruiz-Ortega M, Egido J: Angiotensin II and renal fibrosis. Hypertension 2001;38:635-638.
6. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J: Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001;10:321-329.
7. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993;3:1531-1540.
8. Liu BC, Chen Q, Luo DD, Sun J, Philips AO, Ruan XZ, Liu NF: Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats. Acta Pharmacol Sin 2003;24:67-73.
9. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998;53:853-861.
10. Ito Y, Goldschmeding R, Bende R, Claessen N, Chand M, Kleij L, Rabelink T, Weening J, Aten J: Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis. J Am Soc Nephrol 2001;12:472-484.
11. Wolf G, Ziyadeh FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999;56:393-405.
12. Twigg SM, Chen MM, Joly AH, Chakrapani SD, Tsubaki J, Kim HS, Oh Y, Roserfeld RG: Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein 2) in human fibroblasts: A potential mechanism for expansion of extracellular matrix in diabetes mellitus. Endocrinology 2001;142:1760-1769.
13. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993;22:736-744.
14. Kriz W: Progressive renal failure - inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 1996;11:1738-1742.
15. Wolf G, Neilson EG: Morphogenic cues that modulate podocyte growth. Kidney Int 1998;53:1087-1088.
16. Pagtalunan ME, Miller PL, Jumping-Eagle S, Neilson RG, Myeres BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997;99:342-348.
17. Grotendorst GR: Connective tissue growth factor: A mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 1997;8:171-179.
18. Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991;114:1285-1294.
19. Moussad EE, Brigstock DR: Connective tissue growth factor: What's in a name? Mol Genet Metab 2000;71:276-292.
20. Gupta S, Clarkson MR, Duggan J, Brady HR: Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 2000;58:1389-1399.
21. Oemar BS, Werner A, Garnier JM, Do DD, Godoy N, Nauck M, Marz W, Rupp J, Pech M, Luscher TF: Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 1997;95:831-839.
22. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR: Suppression subtractive hybridization identifies high glucose level as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999;274:5830-5834.
23. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Marins RG: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000;11:25-38.
24. Yokoi H, Sugawara A, Mokoyama M, Mori K, Makino H, Suganami T, Nagae T, Yahata K, Fujinaga Y, Tanaka T, Nakao K: Role of connective tissue growth factor in profibritic action of transforming growth factor-beta: A potential target for preventing renal fibrosis. Am J Kidney Dis 2001;38:s134-s138.
25. Abdel-Wahab N, Weston BS, Roberts T, Mason RM: Connective tissue growth factor and regulation of the mesangial cell cycle: Role in cellular hypertrophy. J Am Soc Nephrol 2002;13:2437-2445.